Cite

HARVARD Citation

    Ghiasi, M. et al. (2021). COVID‐19 infection risk in patients on immunosuppressive/immunomodulator therapy: A single center study. Dermatologic therapy. 34 (6), p. n/a. [Online]. 
  
Back to record